The Trump Administration is leading a realignment on trade, moving away from a unipolar system that really had Asia as the Western world’s manufacturing hub. That is no longer feasible, or affordable.
This month’s tariff agreements with the United Kingdom and China might end up being the first deal of its kind, and the last. On Friday, President Trump reiterated that the administration could not possibly strike deals with every country, and that tariff announcements would be made over the next two to three weeks.
The U.S. must not sacrifice the chance to rebuild industrial capacity in exchange for another empty trade promise to import more American goods, as if these promises will actually materialize.
Importers continued to front-run the April ‘Liberation Day’ tariffs in March, sending the overall trade deficit up 14% over February numbers to $140.5 billion for the month, according to the Bureau of Economic Analysis (BEA) on Tuesday.
Democrats on the Economic Growth, Energy Policy, and Regulatory Affairs Subcommittee—of the House Committee on Oversight and Government Reform—are united against tariffs.
The American people, Congress, and the President have spoken. Now it’s Wall Street’s turn to decide.
Guardian Bikes, an American company out of Seymour, Indiana that sells direct-to-consumer, wants to ensure that it keeps manufacturing 100% of its bicycles right here in the U.S., and to do so, has received a $19 million loan from J.P. Morgan to help them.
Feeding America with abundant, healthy, locally-produced food is as important as any trade or industrial goal. Reinforcing our capacity to feed ourselves makes the nation stronger, safer, and more prosperous, whole the Big Ag status quo blindly follows a globalized model that has left far too many American farms behind.
The Department of Defense designated CATL as a “Chinese military company” under Section 1260H of the National Defense Authorization Act on January 7. Their concern: CATL’s advanced lithium-ion batteries may one day be used to power China’s submarine fleet, replacing older battery models.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
